Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease-Reference-Cited by-同舟云学术

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease

Published:2016-03-10 Issue:5 Volume:263 Page:888-894
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Nicoletti Alessandra,Mostile Giovanni,Nicoletti Giuseppe,Arabia Gennarina,Iliceto Giovanni,Lamberti Paolo,Marconi Roberto,Morgante Letterio,Barone Paolo,Quattrone Aldo,Zappia Mario

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-016-8075-6.pdf

Reference31 articles.

1. Fahn S (2008) The history of dopamine and levodopa in the treatment of Parkinson’s disease. Mov Disord 23:S497–S508

2. Ahlskog JE, Muenter MD (2011) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448–458

3. Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B (2010) Levodopa-induced dyskinesias in patients with Parkinson’s disease: filling the bench-to-bedside gap. Lancet Neurol 9:1106–1117

4. Manson A, Stirpe P, Schrag A (2012) Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life. J Parkinson Dis 21:189–198

5. Olanow CW, Kieburtz K, Rascol O et al (2013) Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson’s disease. Mov Disord 28:1064–1071

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years;Movement Disorders Clinical Practice;2024-04-08

2. Prediction of dyskinesia in Parkinson’s disease patients using machine learning algorithms;Scientific Reports;2023-12-16

3. May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?;Journal of Parkinson's Disease;2023-09-08

4. Levodopa-induced Dyskinesia in Parkinson’s Disease: Plausible Inflammatory and Oxidative Stress Biomarkers;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;2023-01-20

5. Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson’s disease patients;International Journal of Neuroscience;2022-05-31